Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.11 USD | +0.48% | -3.70% | +1.13% |
May. 06 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
May. 06 | Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 2.71M | Sales 2025 * | 2.66M | Capitalization | 2.64B |
---|---|---|---|---|---|
Net income 2024 * | -153M | Net income 2025 * | -196M | EV / Sales 2024 * | 974 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 995 x |
P/E ratio 2024 * |
-17.3
x | P/E ratio 2025 * |
-14
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | +0.48% | ||
1 week | -3.70% | ||
Current month | +7.19% | ||
1 month | +2.19% | ||
3 months | +13.72% | ||
6 months | +48.72% | ||
Current year | +1.13% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +9.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 40.11 | +0.48% | 372,718 |
24-05-10 | 39.92 | -2.78% | 504,888 |
24-05-09 | 41.06 | -0.36% | 445,535 |
24-05-08 | 41.21 | -2.37% | 397,280 |
24-05-07 | 42.21 | +1.34% | 911,674 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.13% | 2.64B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+41.87% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- CLDX Stock